Loading...
Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses
Determining fetal drug exposure (except at the time of birth) is not possible for both logistical and ethical reasons. Therefore, we developed a novel maternal-fetal physiologically based pharmacokinetic (m-f-PBPK) model to predict fetal exposure to drugs and populated this model with gestational ag...
Saved in:
| Published in: | Drug Metab Dispos |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5506457/ https://ncbi.nlm.nih.gov/pubmed/28588050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.117.075192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|